Ferret Models for Henipavirus Infection.


Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2023
Historique:
medline: 24 8 2023
pubmed: 23 8 2023
entrez: 23 8 2023
Statut: ppublish

Résumé

Henipaviruses are emerging zoonotic viruses that can cause outbreaks of severe respiratory and neurological disease in humans and animals such as horses. The mechanism by which these viruses can cause disease remain largely unknown and to date there are no therapeutics or vaccines approved for use in humans. Nipah virus is listed on the World Health Organization R & D Blueprint list of epidemic threats. In order to advance the availability of effective therapeutics and vaccines and medicines that can be used to save lives and avert large scale crises, animal models are required which recapitulate the disease progression in humans. Ferrets are highly susceptible to infection with henipaviruses and develop both severe respiratory and neurological disease. Therefore, the ferret model is highly suitable for studies into both the pathogenesis of henipaviruses, as well as pre-clinical evaluation of intervention strategies.

Identifiants

pubmed: 37610584
doi: 10.1007/978-1-0716-3283-3_15
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

205-217

Informations de copyright

© 2023. Springer Science+Business Media, LLC, part of Springer Nature.

Références

Escaffre O, Borisevich V, Rockx B (2013) Pathogenesis of Hendra and Nipah virus infection in humans. J Infect Dev Ctries 7:308–311
doi: 10.3855/jidc.3648 pubmed: 23592639
Chew MH, Arguin PM, Shay DK, Goh KT, Rollin PE, Shieh WJ, Zaki SR, Rota PA, Ling AE, Ksiazek TG, Chew SK, Anderson LJ (2000) Risk factors for Nipah virus infection among abattoir workers in Singapore. J Infect Dis 181:1760–1763
doi: 10.1086/315443 pubmed: 10823780
Luby SP, Gurley ES, Hossain MJ (2009) Transmission of human infection with Nipah virus. Clin Infect Dis 49:1743–1748
doi: 10.1086/647951 pubmed: 19886791
Luby SP, Rahman M, Hossain MJ, Blum LS, Husain MM, Gurley E, Khan R, Ahmed BN, Rahman S, Nahar N, Kenah E, Comer JA, Ksiazek TG (2006) Foodborne transmission of Nipah virus, Bangladesh. Emerg Infect Dis 12:1888–1894
doi: 10.3201/eid1212.060732 pubmed: 17326940 pmcid: 3291367
O’Sullivan JD, Allworth AM, Paterson DL, Snow TM, Boots R, Gleeson LJ, Gould AR, Hyatt AD, Bradfield J (1997) Fatal encephalitis due to novel paramyxovirus transmitted from horses. Lancet 349:93–95
doi: 10.1016/S0140-6736(96)06162-4 pubmed: 8996421
Bossart KN, Zhu Z, Middleton D, Klippel J, Crameri G, Bingham J, McEachern JA, Green D, Hancock TJ, Chan YP, Hickey AC, Dimitrov DS, Wang LF, Broder CC (2009) A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infection. PLoS Pathog 5:e1000642
doi: 10.1371/journal.ppat.1000642 pubmed: 19888339 pmcid: 2765826
Kurup D, Wirblich C, Feldmann H, Marzi A, Schnell MJ (2015) Rhabdovirus-based vaccine platforms against henipaviruses. J Virol 89:144–154
doi: 10.1128/JVI.02308-14 pubmed: 25320306
Lo MK, Bird BH, Chattopadhyay A, Drew CP, Martin BE, Coleman JD, Rose JK, Nichol ST, Spiropoulou CF (2014) Single-dose replication-defective VSV-based Nipah virus vaccines provide protection from lethal challenge in Syrian hamsters. Antivir Res 101:26–29
doi: 10.1016/j.antiviral.2013.10.012 pubmed: 24184127
McEachern JA, Bingham J, Crameri G, Green DJ, Hancock TJ, Middleton D, Feng YR, Broder CC, Wang LF, Bossart KN (2008) A recombinant subunit vaccine formulation protects against lethal Nipah virus challenge in cats. Vaccine 26:3842–3852
doi: 10.1016/j.vaccine.2008.05.016 pubmed: 18556094 pmcid: 6186147
van Doremalen N, Lambe T, Sebastian S, Bushmaker T, Fischer R, Feldmann F, Haddock E, Letko M, Avanzato VA, Rissanen I, LaCasse R, Scott D, Bowden TA, Gilbert S, Munster V (2019) A single-dose ChAdOx1-vectored vaccine provides complete protection against Nipah Bangladesh and Malaysia in Syrian golden hamsters. PLoS Negl Trop Dis 13:e0007462
doi: 10.1371/journal.pntd.0007462 pubmed: 31170144 pmcid: 6581282
Food, Drug Administration HHS (2002) New drug and biological drug products; evidence needed to demonstrate effectiveness of new drugs when human efficacy studies are not ethical or feasible. Final rule. Fed Regist 67:37988–37998
Rockx B (2014) Recent developments in experimental animal models of Henipavirus infection. Pathog Dis doi. https://doi.org/10.1111/2049-632X.12149
Middleton DJ, Westbury HA, Morrissy CJ, van der Heide BM, Russell GM, Braun MA, Hyatt AD (2002) Experimental Nipah virus infection in pigs and cats. J Comp Pathol 126:124–136
doi: 10.1053/jcpa.2001.0532 pubmed: 11945001
Dhondt KP, Mathieu C, Chalons M, Reynaud JM, Vallve A, Raoul H, Horvat B (2013) Type I interferon signaling protects mice from lethal henipavirus infection. J Infect Dis 207:142–151
doi: 10.1093/infdis/jis653 pubmed: 23089589
Geisbert TW, Daddario-DiCaprio KM, Hickey AC, Smith MA, Chan YP, Wang LF, Mattapallil JJ, Geisbert JB, Bossart KN, Broder CC (2010) Development of an acute and highly pathogenic nonhuman primate model of Nipah virus infection. PLoS One 5:e10690
doi: 10.1371/journal.pone.0010690 pubmed: 20502528 pmcid: 2872660
Pallister J, Middleton D, Wang LF, Klein R, Haining J, Robinson R, Yamada M, White J, Payne J, Feng YR, Chan YP, Broder CC (2011) A recombinant Hendra virus G glycoprotein-based subunit vaccine protects ferrets from lethal Hendra virus challenge. Vaccine 29:5623–5630
doi: 10.1016/j.vaccine.2011.06.015 pubmed: 21689706 pmcid: 3153950
Rockx B, Bossart KN, Feldmann F, Geisbert JB, Hickey AC, Brining D, Callison J, Safronetz D, Marzi A, Kercher L, Long D, Broder CC, Feldmann H, Geisbert TW (2010) A novel model of lethal Hendra virus infection in African green monkeys and the effectiveness of ribavirin treatment. J Virol 84:9831–9839
doi: 10.1128/JVI.01163-10 pubmed: 20660198 pmcid: 2937751
Williamson MM, Hooper PT, Selleck PW, Westbury HA, Slocombe RF (2000) Experimental hendra virus infectionin pregnant Guinea-pigs and fruit bats (Pteropus poliocephalus). J Comp Pathol 122:201–207
doi: 10.1053/jcpa.1999.0364 pubmed: 10684689
Wong KT, Grosjean I, Brisson C, Blanquier B, Fevre-Montange M, Bernard A, Loth P, Georges-Courbot MC, Chevallier M, Akaoka H, Marianneau P, Lam SK, Wild TF, Deubel V (2003) A golden hamster model for human acute Nipah virus infection. Am J Pathol 163:2127–2137
doi: 10.1016/S0002-9440(10)63569-9 pubmed: 14578210 pmcid: 1892425
Smith H, Sweet C (1988) Lessons for human influenza from pathogenicity studies with ferrets. Rev Infect Dis 10:56–75
doi: 10.1093/clinids/10.1.56 pubmed: 3281223
Clayton BA, Middleton D, Bergfeld J, Haining J, Arkinstall R, Wang L, Marsh GA (2012) Transmission routes for nipah virus from Malaysia and Bangladesh. Emerg Infect Dis 18:1983
doi: 10.3201/eid1812.120875 pubmed: 23171621 pmcid: 3557903
Mire CE, Versteeg KM, Cross RW, Agans KN, Fenton KA, Whitt MA, Geisbert TW (2013) Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease. Virol J 10:353
doi: 10.1186/1743-422X-10-353 pubmed: 24330654 pmcid: 3878732
Pallister JA, Klein R, Arkinstall R, Haining J, Long F, White JR, Payne J, Feng YR, Wang LF, Broder CC, Middleton D (2013) Vaccination of ferrets with a recombinant G glycoprotein subunit vaccine provides protection against Nipah virus disease for over 12 months. Virol J 10:237
doi: 10.1186/1743-422X-10-237 pubmed: 23867060 pmcid: 3718761
Leon AJ, Banner D, Xu L, Ran L, Peng Z, Yi K, Chen C, Xu F, Huang J, Zhao Z, Lin Z, Huang SH, Fang Y, Kelvin AA, Ross TM, Farooqui A, Kelvin DJ (2013) Sequencing, annotation, and characterization of the influenza ferret infectome. J Virol 87:1957–1966
doi: 10.1128/JVI.02476-12 pubmed: 23236062 pmcid: 3571481
Leon AJ, Borisevich V, Boroumand N, Seymour R, Nusbaum R, Escaffre O, Xu L, Kelvin DJ, Rockx B (2018) Host gene expression profiles in ferrets infected with genetically distinct henipavirus strains. PLoS Negl Trop Dis 12:e0006343
doi: 10.1371/journal.pntd.0006343 pubmed: 29538374 pmcid: 5868854
Barthold SW, Bayne KA, Davis MA (2011) Guide for the care and use of laboratory animals. National Academy Press, Washington

Auteurs

Barry Rockx (B)

Wageningen Bioveterinary Institute, Lelystad and Department of Viroscience, Erasmus University Medical Center, Rotterdam, The Netherlands. Barry.rockx@wur.nl.

Chad E Mire (CE)

Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA.
Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH